Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development

Qiang Hao1, Xiaozhao Lu, Nannan Liu

  • 1The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University, Xi'an 710032, China.

BMB Reports
|June 25, 2013
PubMed

Insights

Gastric cancer involves increased c-SRC (SRC) protein. Tumor suppressive microRNAs miR34a and miR203 target SRC, inhibiting cancer cell growth and migration, offering a potential new therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer is a leading cause of cancer mortality worldwide.
  • Upregulated nonreceptor tyrosine kinase c-SRC (SRC) is implicated in gastric cancer development.
  • SRC protein levels are elevated in clinical gastric cancer samples, more so than RNA levels.

Purpose of the Study:

  • To investigate the role of posttranscriptional regulation in SRC expression in gastric cancer.
  • To explore the relationship between tumor suppressive microRNAs (miRNAs) and SRC expression.
  • To evaluate the therapeutic potential of targeting SRC via miRNAs in gastric cancer.

Main Methods:

  • Analysis of SRC expression in clinical gastric cancer samples.
  • Correlation studies between SRC expression and tumor suppressive miRNAs (miR34a, miR203).
  • Restoration of miR34a and miR203 in gastric cancer cell lines to assess effects on SRC expression, cell growth, and migration.

Main Results:

  • SRC expression, particularly at the protein level, is significantly increased in gastric cancer.
  • Expression of tumor suppressive miRNAs miR34a and miR203 inversely correlates with SRC expression.
  • Restoring miR34a and miR203 reduced SRC levels, inhibiting gastric cancer cell growth and migration.

Conclusions:

  • Posttranscriptional regulation of SRC by miR34a and miR203 plays a crucial role in gastric cancer progression.
  • Targeting SRC using miR34a or miR203 mimics presents a promising therapeutic strategy for gastric cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...